Skip to main content
. 2022 Dec;23(12):4275–4284. doi: 10.31557/APJCP.2022.23.12.4275

Table 4.

Attitude of Oncologists Toward Chemotherapy Resistance

Items Strongly
Disagree
Disagree Uncertain Agree Strongly
Agree
1. Chemotherapy resistance is the patient's fault. 8 (12.5) 39 (60.9) 11 (17.2) 4 (6.3) 2 (3.2)
2. Chemotherapy resistance is the oncologist's fault. 6 (9.6) 38 (59.4) 11 (17.2) 5 (7.8) 4 (6.3)
3. If proper steps are taken, chemotherapy resistance can be combated. 0 (0) 12 (18.8) 29 (45.3) 18 (28.1) 5 (7.8)
4. I am confident that we can still beat cancer disease successfully after incidence
of chemotherapy resistance.
0 (0) 3 (4.7) 16 (25) 41 (64.1) 4 (6.3)
5. If a patient receives proper information about the risk of chemotherapy resistance,
it can be avoided
2 (3.2) 18 (28.1) 21 (32.8) 21 (32.8) 2 (3.2)
6. Oncologists should fully assess factors that cause chemotherapy resistance in patients before commencing chemotherapy treatment 1 (1) 2 (3.2) 12 (18.8) 46 (71.9) 3 (4.7)
7. I am satisfied with the current treatment guideline to treat chemotherapy resistance 1 (1.6) 5 (7.8) 20 (31.3) 32 (50) 6 (9.4)
8. Rapid and effective diagnostic techniques are required for diagnosis of chemotherapy resistance 0 (0) 2 (3.2) 10 (15.6) 51 (79.7) 1 (1.6)
9. Personalizing chemotherapy treatment will help to prevent and/or overcome
chemotherapy resistance problem
0 (0) 11 (17.2) 24 (37.5) 28 (43.8) 1 (1.6)
10. National and healthcare policies are impractical against chemotherapy resistance 0 (0) 10 (15.6) 37 (57.8) 14 (21.9) 3 (4.7)
11. Some chemotherapy resistance stems from genetic factors and it cannot be rectified. 0 (0) 4 (6.3) 26 (40.6) 32 (50) 2 (3.2)
12. The patients’ coping mechanisms have a bearing on their ability to overcome
drug resistance.
0 (0) 10 (15.6) 35 (54.7) 17 (26.6) 2 (3.2)
13. Chemotherapy resistance decreases the chance of survival 0 (0) 5 (7.8) 15 (23.4) 38 (59.4) 6 (9.4)
Attitude level (N=64) Negative attitude: 26 (40.6%)
Positive attitude: 38 (59.4%)